Jeffrey J. Hessekiel, J.D., is Executive Vice President and General Counsel at Exelixis. In this role since February 2014, Mr. Hessekiel’s responsibilities include helping colleagues across Exelixis successfully navigate the complex legal and regulatory landscape as they work to create medicines that improve the lives of patients living with cancer, as well as protecting Exelixis and advancing its interests as consistent with Exelixis’ Code of Conduct.

Prior to joining Exelixis, Mr. Hessekiel was Senior Counsel at Arnold & Porter Kaye Scholer LLP, where he advised emerging growth and public companies, primarily in the life sciences sector, on complex legal issues connected with strategic transactions, healthcare compliance programs and investigations, and regulatory matters. Previously, from 2002 to 2012, he held key legal and compliance roles at Gilead Sciences, Inc., rising to the positions of Vice President, Commercial Legal Affairs and Litigation, and later Chief Compliance and Quality Officer, where he was responsible for the creation and management of Gilead’s Corporate Compliance & Quality department. Earlier in his career, Mr. Hessekiel trained in the litigation and corporate practice groups at a number of Silicon Valley law firms. He also worked for several international non-governmental organizations.

Mr. Hessekiel holds a J.D. from The George Washington University Law School and is admitted to practice in California and he holds a B.A. in Political Science from Duke University.

‍